KeyBanc Starts LeMaitre Vascular (LMAT) at Sector Weight

February 12, 2021 8:20 AM EST
Get Alerts LMAT Hot Sheet
Price: $50.47 -0.04%

Rating Summary:
    7 Buy, 4 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 18 | Down: 20 | New: 68
Trade Now! 
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.

KeyBanc analyst Matthew Mishan initiates coverage on LeMaitre Vascular (NASDAQ: LMAT) with a Sector Weight rating.

The analyst commented, "LMAT is not a typical MedTech company, and more closely resembles a diverse but concentrated private equity portfolio focused on open vascular surgery and capital returns. More specifically: 1) products are sticky with typically high market share; 2) we believe its LT organic growth profile could be MSD; 3) while competitors innovate toward minimally invasive procedures around its addressable markets, it stays a step ahead with M&A; 4) capital allocation is enabled by profitability and FCF; and 5) valuation vs. peers is a balance between higher industry growth expectations and LMAT's stronger profitability."

For an analyst ratings summary and ratings history on LeMaitre Vascular click here. For more ratings news on LeMaitre Vascular click here.

Shares of LeMaitre Vascular closed at $47.53 yesterday.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst Comments, New Coverage

Related Entities

KeyBanc